During the past decade, Berks Cardiologists, Ltd. conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 10 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Berks Cardiologists, Ltd." #1 sponsor was "Pfizer" with 5 trials, followed by "Astellas Pharma Global Development, Inc." with 1 trials sponsored, "Baim Institute for Clinical Research" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "CardioDx" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Berks Cardiologists, Ltd." #1 collaborator was "ClinLogix. LLC" with 2 trials as a collaborator, "Massachusetts General Hospital" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Beth Israel Deaconess Medical Center" with 1 trials as a collaborator and "Boston Scientific Corporation" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Berks Cardiologists, Ltd." are "Coronary Artery Disease" (5 trials), "Hyperlipidemia" (3 trials), "Cardiovascular Disease" (2 trials), "Coronary Artery Disease (CAD)" (2 trials) and "Angina Pectoris" (1 trials). Many other conditions were trialed in "Berks Cardiologists, Ltd." in a lesser frequency.

Most popular intervention types in "Berks Cardiologists, Ltd." are "Drug" (9 trials), "Device" (5 trials), "Other" (3 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Bococizumab (PF-04950615;RN316)" (2 trials), "bococizumab (PF-04950615)" (2 trials), "99mTechnicium (sestamibi or tetrofosmin)" (1 trials) and "Atorvastatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Berks Cardiologists, Ltd." are 16 trials for "All" genders.

Currently, there are NaN active trials in "Berks Cardiologists, Ltd.". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Berks Cardiologists, Ltd., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Berks Cardiologists, Ltd., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".